LDLs induce fibroblast spreading independently of the LDL receptor via activation of the p38 MAPK pathway

Journal of Lipid Research

Volumn 44, Issue 12, 2003, Pages 2382-2390

  Dobreva, Iveta ^a   Waeber, Gérard ^b   Mooser, Vincent ^b   James, Richard W ^c   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cell spreading; Fibroblasts; Lamellipodia; Lipoproteins; Low density lipoprotein; Low density lipoprotein receptor; P38 mitogen activated protein kinase; Remodeling

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CELL SHAPE; CELL SPREADING; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; LAMELLIPODIUM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ANIMALS; CELL SIZE; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPROTEINS, LDL; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PSEUDOPODIA; RECEPTORS, LDL; SKIN;

EID: 0347724148     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300266-JLR200     Document Type: Article

References (32)

1. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. The road ahead. Cell. 104: 503-516.
2. Martin, M. J., S. B. Hulley, W. S. Browner, L. H. Kuller, and D. Wentworth. 1986. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 2: 9: 33-936.
3. Gouni-Berthold, I., and A. Sachinidis. 2002. Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J. 16: 1477-1487.
4. Zhu, Y., H-L. Liao, N. Wang, O. Friedli, Jr., L. Verna, and M. B. Stemerman. 1999. Low-density lipoprotein activates Jun N-terminal kinase (JNK) in human endothelial cells. Biochim. Biophys. Acta. 1436: 557-564.
5. Metzler, B., Y. Hu, H. Dietrich, and Q. Xu. 2000. Increased expression and activation of stress-activated protein kinases/c-Jun NH (2)-terminal protein kinases in atherosclerotic lesions coincide with p53. Am. J. Pathol. 156: 1875-1886.
6. Sartore, S., A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto. 2001. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ. Res. 89: 1111-1121.
7. Havel, R. J., H. A. Eder, and J. H. Bragton. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
8. James, R. W., and D. Pometta. 1990. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis. 83: 35-45.
9. Wolff, S. P. 1994. Ferrous ion oxidation in the presence of the ferric ion indicator xylenol orange for the measure of hydroperoxides: the FOX assay. Methods Enzymol. 233: 182-189.
10. Brown, M. S., and J. L. Goldstein. 1974. Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc. Natl. Acad. Sci. USA. 71: 788-792.
11. Widmann, C., P. Gerwins, N. Lassignal Johnson, M. B. Jarpe, and G. L. Johnson. 1998. MEKK1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18: 2416-2429.
12. Yang, J-Y., and C. Widmann. 2001. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol. Cell. Biol. 21: 5346-5358.
13. Aplin, A. E., B. P. Hogan, J. Tomeu, and R. L. Juliano. 2002. Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinases. J. Cell Sci. 115: 2781-2790.
14. Busso, N., J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser. 2001. Plasma apolipoprotein(a) co-deposits Aith fibrin in inflammatory arthritic joints. Am. J. Pathol. 159: 1445-1453.
15. Ouwens, D. M., N. D. de Ruiter, G. C. van der Zon, A. P. Carter, J. Schouten, B. C. van der Burgt, K. Kooistra, J. L. Bos, J. A. Maassen, and H. van Dam. 2002. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21: 3782-3793.
16. Lee, H., and W. Bai. 2002. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22: 5835-5845.
17. Kim, S. O., K. Ono, and J. Han. 2001. Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages. Am. J. Physiol. Lung Cell. Biol. Physiol. 281: L1095-L1105.
18. Jing, Q., S. M. Xin, Z. J. Cheng, W. B. Zhang, R. Zhang, Y. W. Qin, and G. Pei. 1999. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: Mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ. Res. 84: 831-839.
19. Edwards, P. A., D. Tabor, H. R. Kast, and A. Venkateswaran. 2000. Regulation of gene expression by SREBP and SCAP. Biochim. Biophys. Acta. 1529: 103-113.
20. Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15: 2169-2177.
21. Widmann, C., S. Gibson, M. B. Jarpe, and G. L. Johnson. 1999. MAPK pathways: conservation of a three-kinase module from yeast to man. Physiol. Rev. 79: 143-180.
22. Hackeng, C. M., I. A. Relou, M. W. Pladet, G. Gorter, H. J. van Rijn, and J. W. Akkerman. 1999. Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb. Haemost. 82: 1749-1756.
23. Zhao, M., Y. Liu, X. Wang, L. New, J. Han, and U. T. Brunk. 2002. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS. 110: 458-468.
24. Gouni-Berthold, I., H. K. Berthold, A. A. Weber, C. Seul, H. Vetter, and A. Sachinidis. 2001. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth. Exp. Clin. Endocrinol. Diabetes. 109: 203-209.
25. Zhu, Y., H. Liao, N. Wang, K. S. Ma, L. K. Verna, J. Y. Shyy, S. Chien, and M. B. Stemerman. 2001. LDL-activated p38 in endothelial cells is mediated by Ras. Arterioscler. Thromb. Vasc. Biol. 21: 1159-1164.
26. Sachinidis, A., S. Seewald, P. Epping, C. Seul, Y. Ko, and H. Vetter. 1997. The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol. Pharmacol. 52: 389-397.
27. Ezaki, M., J. L. Witztum, and D. Steinberg. 1995. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J. Lipid Res. 36: 1996-2004.
28. Sigari, F., C. Lee, J. L. Witztum, and P. D. Reaven. 1997. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. Arterioscler. Thromb. Vasc. Biol. 17: 3639-3645.
29. Jing, Q., S. M. Xin, W. B. Zhang, P. Wang, Y. W. Qin, and G. Pei. 2000. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ. Res. 87: 52-59.
30. Takahashi, M., H. Okazaki, Y. Ogata, K. Takeuchi, U. Ikeda, and K. Shimada. 2002. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis. 161: 387-394.
31. Goldstein, J. L., and M. S. Brown. 2001. Molecular medicine. The cholesterol quartet. Science. 292: 1310-1312.
32. Ohashi, N., A. Matsumori, Y. Furukawa, K. Ono, M. Okada, A. Iwasaki, T. Miyamoto, A. Nakano, and S. Sasayama. 2000. Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler. Thromb. Vasc. Biol. 20: 2521-2526.